Eric S Fain

CIK 1402222 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 30, 2023 · Latest: Jan. 30, 2023

On this page

Insider at

Insider transactions

2 buys (P) 0 sells (S) Net: $97,634 + 36 non-open-market transactions below Avg return of open purchases vs now: 71.0% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

36 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 14, 2026 OBIO P 20,000 $4.13 $82,600 91,709 Indirect +27.89% Acquired 32.4% (price as of 2026-08-20)
Aug. 25, 2025 OBIO P 5,760 $2.61 $15,034 71,709 Indirect +8.73% Acquired 109.6% (price as of 2026-08-20)
June 26, 2025 OBIO S 2,683 $3.05 $8,183 50,949 Indirect -5.00% Disposed 79.3% (price as of 2026-08-20)
Sept. 10, 2024 OBIO S 1,800 $5.34 $9,612 41,210 Indirect -4.19% Disposed 2.4% (price as of 2026-08-20)
Sept. 9, 2024 OBIO S 1,800 $5.43 $9,774 43,010 Indirect -4.02% Disposed 0.7% (price as of 2026-08-20)
Sept. 6, 2024 OBIO S 2,000 $5.64 $11,280 44,810 Indirect -4.27% Disposed -3.0% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 23, 2026 OBIO Stock Option (Right to Buy) Common Stock (21,277) $4.04 June 23, 2036 21,277 Acquired
June 24, 2025 OBIO Stock Option (Right to Buy) Common Stock (36,797) $3.22 June 24, 2035 36,797 Acquired
June 20, 2024 OBIO Stock Option (Right to Buy) Common Stock (17,068) $7.44 June 20, 2034 17,068 Acquired
July 20, 2023 OBIO Stock Option (Right to Buy) Common Stock (17,500) $7.42 July 20, 2033 17,500 Acquired
May 10, 2023 OBIO Warrant (Right to Buy) Common Stock (2,906) $1.08 May 31, 2023 2,906 Disposed
April 12, 2023 OBIO Right to Receive Earnout Shares Common Stock (4,796) 4,796 Disposed
Jan. 26, 2023 OBIO Nonstatutory Stock Option (Right to Buy) [F1] Common Stock (23,250) $10.00 Aug. 17, 2032 23,250 Acquired
Jan. 26, 2023 OBIO Right to Receive Earnout Shares [F1] Common Stock (9,592) 9,592 Acquired
Jan. 26, 2023 OBIO Warrant (Right to Buy) Common Stock (2,906) $1.08 May 31, 2023 2,906 Acquired
Jan. 26, 2023 OBIO Nonstatutory Stock Option (Right to Buy) Common Stock (23,250) $10.00 Aug. 25, 2032 23,250 Acquired
Jan. 26, 2023 OBIO Nonstatutory Stock Option (Right to Buy) Common Stock (6,975) $4.30 Aug. 6, 2029 6,975 Acquired
Jan. 26, 2023 OBIO Nonstatutory Stock Option (Right to Buy) Common Stock (18,600) $4.30 Nov. 16, 2028 18,600 Acquired
Feb. 17, 2017 ABT Option (right to buy) [F3] Common shares (159,657) $44.40 Feb. 16, 2027 159,657 Acquired
Jan. 4, 2017 ABT Option (right to buy) Common shares without par value (163,268) $29.56 Dec. 7, 2023 163,268 Acquired
Jan. 4, 2017 ABT Option (right to buy) Common shares without par value (85,864) $33.14 Dec. 8, 2022 85,864 Acquired
Jan. 4, 2017 ABT Option (right to buy) Common shares without par value (44,387) $28.50 Dec. 10, 2021 44,387 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 30, 2023 OBIO Warrants (Right to Buy)→ Common Stock, par value $0.0001 per share ("Common Stock") (15,000) 15,000 Direct
July 25, 2017 ABT Common shares without par value Direct
Jan. 6, 2017 ABT Common shares without par value 1,500 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ABT

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2017 $556,971 $0 $3,024,589 $1,024,998 $174,700 $13,330,823 $8,549,565 $13,330,823

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.